Repligen Corp. (RGEN)

122.80 -2.17 (-1.74%) USD  |  NASDAQ  |  Mar 03, 13:02
More

Repligen Extraordinary Items, Income Statement (Quarterly)

Extraordinary Items, Income Statement (Quarterly) Chart

View Extraordinary Items, Income Statement (Quarterly) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Extraordinary Items, Income Statement (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years

View Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Extraordinary Items, Income Statement (Quarterly) Benchmarks

View Extraordinary Items, Income Statement (Quarterly) Benchmarks
Start Trial
Orthofix Medical, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Abbott Laboratories Upgrade
Accuray, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade